Maria - US: Lupus, Fibromyalgia, Sjogren's (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Maria is from Argentina and now lives in the United states, in California, and is using low dose naltrexone (LDN) for lupus, fibromyalgia and Sjogren's syndrome

Margaret - US: Cushing's, Hashimoto's, PCOS, Arthritis, Depression (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Margaret from the United States who takes LDN. Thank you for joining me, Margaret.

Margaret: Hi,

Margaret - Spain: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Margaret, previously  from England but now from Spain, was diagnosed with multiple sclerosis (MS) in 2008. She has had MS ever since she was near 20 years old, and is now 60. 

 

Malcolm from the United States, takes Low Dose Naltrexone (LDN) for multiple sclerosis (MS). He was diagnosed around 1991, in his early thirties. Now 53. 

Before his diagnosis, Malcolm was involved in sports. He worked for a large corporation in sales and marketing, as well as having a child.  

At first his optic neuritis, which was treated with steroids, did not affect his life too much but stopped him with the sports. Malcolm did not know about LDN until around 2003, 2004,where he learnt about it over the internet. 

Maija - US: Chronic Fatigue Syndrome (CFS/ME) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Maija from Finland shares her Chronic Fatigue Syndrome (CFS/ME) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Lynn - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Lynn from England shares their Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Lynn - Australia: Graves Disease, Nephropathy (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Lynn from Australia shares her Graves Disease and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.